ASTH: Rounding Bottom detected on 19 May 2026

ASTH has formed a rounding bottom pattern with solid structural integrity (15/15 score). The stock is trading at $38.98, approximately 2.4% below its 52-week high of $39.80, having recovered 115.6% from the 52-week low of $18.08. Key support lies at $18.08 with resistance at $31.96. The conservative breakout target is $40.67. Volume scores 10/10, though current volume (491,740 shares) sits at 0.97x the 20-day average, indicating modest trading intensity. The breakout score of 7/13 suggests moderate technical confirmation potential. Overall pattern quality: 65/98, with a 60.84% win probability.

Astrana Health reported Q1 2026 revenue of $965.1 million (up 56% YoY) and net income of $14.4 million, driven by its value-based care model and the 2025 Prospect acquisition. The company delivered EPS of $0.74, far exceeding the forecasted $0.29, marking a 155.17% surprise. On the earnings announcement day (May 7), ASTH gained 8.92%, with a peak intraday move of +20.7%. Management reaffirmed full-year 2026 guidance for revenue of $3.8B–$4.1B, adjusted EBITDA of $250M–$280M, and free cash flow of $105M–$132.5M. Analysts maintain a bullish consensus "Buy" rating with price targets ranging from $26 to $50. The rounding bottom is forming post-earnings in a favorable fundamental backdrop of strong growth and operational leverage.

A successful breakout above resistance at $31.96 would confirm the rounding bottom completion, with the conservative measured move target at $40.67—a gain of approximately 4.3% from current price. The pattern suggests buyers should watch for volume expansion on any move above resistance; current volume is tracking near average, so breakout confirmation would ideally include a volume spike above the 20-day mean of 505,863 shares. The setup invalidates below the key support level of $18.08. With a 60.84% win probability, historical backtests suggest this structure is moderately reliable. The technical setup aligns with the bullish market regime (0.85 score), though Consumer Discretionary sector headwinds (-0.4 regime score) represent a structural headwind.

ASTH trades at an RSI of 70.89, indicating overbought conditions that increase near-term correction risk. Customer concentration is material: one major payer accounted for 20.9% of Q1 2026 revenue and 39.2% of receivables, creating exposure to contract or payment changes. Total debt stands at $1.04 billion with quarterly interest expense of $16.1 million, reflecting reliance on acquisition financing. Beta is low at 0.42, but 20-day volatility is elevated at 44.4%, suggesting price swings could disrupt the pattern. The Consumer Discretionary sector trades in bearish regime (-0.4), which may weigh on healthcare service names. No near-term earnings catalyst exists beyond Q2 guidance, reducing catalytic support for sustained breakout momentum.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.